Show simple item record

dc.contributor.authorC. Steer, Andrewen_US
dc.contributor.authorMagor, Grahamen_US
dc.contributor.authorW. J. Jenney, Adamen_US
dc.contributor.authorKado, Josephen_US
dc.contributor.authorF. Good, Michaelen_US
dc.contributor.authorMcMillan, Daviden_US
dc.contributor.authorBatzloff, Michaelen_US
dc.contributor.authorR. Carapetis, Jonathanen_US
dc.date.accessioned2017-04-24T12:19:15Z
dc.date.available2017-04-24T12:19:15Z
dc.date.issued2008en_US
dc.date.modified2011-08-12T06:21:24Z
dc.identifier.issn0095-1137en_US
dc.identifier.doi10.1128/JCM.00312-09en_AU
dc.identifier.urihttp://hdl.handle.net/10072/39960
dc.description.abstractWe designed a study to investigate the molecular epidemiology of group A streptococcal (GAS) and group C and G streptococcal (GCS and GGS) disease in Fiji, a country which is known to have a high burden of streptococcal disease. Molecular typing of the N-terminal portion (emm typing) of the M protein was performed with 817 isolates (535 GAS and 282 GCS/GGS). We also performed genotyping of the C-repeat region in 769 of these isolates to identify J14 sequence types. The profile of emm types for Fiji was very different from that found for the United States and Europe. There were no dominant emm types and a large number of overlapping types among clinical disease states. Commonly found GAS emm types in industrialized countries, including emm1, emm12, and emm28, were not found among GAS isolates from Fiji. Over 93% of GAS isolates and over 99% of GCS/GGS isolates that underwent J14 sequence typing contained either J14.0 or J14.1. Our data have implications for GAS vaccine development in developing countries and suggest that a vaccine based upon the conserved region of the M protein may be a feasible option for Fiji and potentially for other tropical developing countries.en_US
dc.description.peerreviewedYesen_US
dc.description.publicationstatusYesen_AU
dc.languageEnglishen_US
dc.language.isoen_AU
dc.publisherAmerican Society for Microbiologyen_US
dc.publisher.placeUnited Statesen_US
dc.relation.ispartofstudentpublicationNen_AU
dc.relation.ispartofpagefrom2502en_US
dc.relation.ispartofpageto2509en_US
dc.relation.ispartofissue8en_US
dc.relation.ispartofjournalJournal of Clinical Microbiologyen_US
dc.relation.ispartofvolume47en_US
dc.rights.retentionYen_AU
dc.subject.fieldofresearchMicrobiology not elsewhere classifieden_US
dc.subject.fieldofresearchcode060599en_US
dc.titleemm and C-Repeat Region Molecular Typing of Beta-Hemolytic Streptococci in a Tropical Country: Implications for Vaccine Developmenten_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Peer Reviewed (HERDC)en_US
dc.type.codeC - Journal Articlesen_US
gro.date.issued2008
gro.hasfulltextNo Full Text


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record